Journal
MOVEMENT DISORDERS
Volume 36, Issue 6, Pages 1392-1400Publisher
WILEY
DOI: 10.1002/mds.28507
Keywords
non‐ motor fluctuations; non‐ motor symptoms; questionnaire; validation; Parkinson' s disease
Categories
Funding
- Sunovion Pharmaceuticals sponsorship through the Parkinson Study Group
Ask authors/readers for more resources
The study validated a final version of a 27-item self-administered NoMoFA questionnaire, capable of effectively capturing both static and fluctuating non-motor symptoms in Parkinson's disease patients. The questionnaire showed good internal consistency, test-retest reliability, and concurrent validity, and underwent item reduction through a Delphi process, resulting in high acceptability.
Background In patients with Parkinson's disease (PD), sleep, mood, cognitive, autonomic, and other non-motor symptoms may fluctuate in a manner similar to motor symptoms. Objectives To validate a final version of a patient-rated questionnaire that captures the presence and severity of non-motor fluctuations in levodopa-treated PD patients (NoMoFA). Methods We recruited PD subjects from five movement disorders centers across the US and Canada. We assessed the internal consistency, floor and ceiling effects, test-retest reliability, and concurrent validity of NoMoFA. Classical test theory and item response theory methods informed item reduction and Delphi process yielded a final questionnaire. Results Two hundred subjects and their care-partners participated in the study (age: 66.4 +/- 9.6 years; disease duration: 9 +/- 5.5 years; median Hoehn and Yahr [H&Y] OFF: 3 [range 1-5]; mean Unified Parkinson's Disease Rating Scale (UPDRS) III ON score: 27.4 +/- 14.9). Acceptability of the scale was adequate. There were floor effects in 8/28 items. Cronbach's alpha was 0.894. While eight items had item-to-total correlations below the cutoff of 0.4, removing these items did not improve Cronbach's alpha. Test-retest reliability was acceptable (intraclass correlation coefficient [ICC] 0.73; 95% confidence interval, 0.64-0.80). Concurrent validity was adequate with all Spearman's rho values comparing NoMoFA score to other measures of parkinsonian severity showing significance and in the expected direction. A final Delphi panel eliminated one item to avoid redundancy. Conclusions The final 27-item self-administered NoMoFA is a valid and reliable questionnaire, capturing both static and fluctuating non-motor symptoms in PD. (c) 2021 International Parkinson and Movement Disorder Society
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available